GABA B receptors involvement in the effects induced by nicotine on anxiety-related behaviour in mice

Pharmacological Research

Volumn 65, Issue 5, 2012, Pages 507-513

  Varani, Andrés P ^a   Balerio, Graciela N ^a,b  

^a Instituto de Investigaciones Farmacologicas   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

2 OH saclofen; Anxiety; Baclofen; GABA B receptors; Mice; Nicotine

Indexed keywords

2 HYDROXYSACLOFEN; 4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN; NICOTINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; BEHAVIOR CONTROL; DRUG DOSE COMPARISON; MALE; MAZE TEST; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BACLOFEN; BEHAVIOR, ANIMAL; GABA-B RECEPTOR AGONISTS; GABA-B RECEPTOR ANTAGONISTS; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; NICOTINE; RECEPTORS, GABA-B; TOBACCO USE DISORDER;

EID: 84859788266     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2012.03.001     Document Type: Article

References (45)

1. Novick LF. Smoking is the leading preventable cause of death and disability in the United States. J Public Health Manag Pract 2000;6(3):VI.
2. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000;321(7257):323-9. (Pubitemid 30496873)
3. Decker MW, Brioni JD, Bannon AW, Arneric SP. Diversity of neuronal nicotinic acetylcholine receptors: lessons from behaviour and implications for CNS therapeutics. Life Sci 1995;56(8):545-70.
4. Dani JA. Overview of nicotinic receptors and their roles in the central nervous system. Biol Psychiatry 2001;49(3):166-74. (Pubitemid 32178425)
5. Pomerleau OF. Nicotine as a psychoactive drug: anxiety and pain reduction. Psychopharmacol Bull 1986;22(3):865-9. (Pubitemid 17183396)
6. Gilbert DG, Robinson JH, Chamberlin CL, Spielberger CD. Effects of smoking/nicotine on anxiety, heart rate, and lateralization of EEG during a stressful movie. Psychophysiology 1989;26(3):311-20. (Pubitemid 19162443)
7. O'Neill AB, Brioni JD. Benzodiazepine receptor mediation of the anxiolyticlike effect of (-)-nicotine in mice. Pharmacol Biochem Behav 1994;49(3):755-7. (Pubitemid 24335664)
8. Biala G, Budzynska B. Effects of acute and chronic nicotine on elevated plus maze in mice: involvement of calcium channels. Life Sci 2006;79(1):81-8.
9. Balerio GN, Aso E, Maldonado R. Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl) 2005;181(2):260-9. (Pubitemid 41492196)
10. Balerio GN, Aso E, Maldonado R. Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl) 2006;184(3-4):504-13. (Pubitemid 43255867)
11. Brioni JD, O'Neill AB, Kim DJ, Decker MW. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur J Pharmacol 1993;238(1):1-8. (Pubitemid 23197854)
12. Seth P, Cheeta S, Tucci S, File SE. Nicotinic - serotonergic interactions in brain and behaviour. Pharmacol Biochem Behav 2002;71(4):795-805. (Pubitemid 34219229)
13. File SE, Cheeta S, Kenny PJ. Neurobiological mechanisms by which nicotine mediates different types of anxiety. Eur J Pharmacol 2000;393(1-3):231-6. (Pubitemid 30193421)
14. Dalvi A, Rodgers RJ. GABAergic influences on plus-maze behaviour in mice. Psychopharmacology (Berl) 1996;128(4):380-97. (Pubitemid 26417680)
15. Balerio GN, Rubio MC. Baclofen analgesia: involvement of the GABAergic system. Pharmacol Res 2002;46(3):281-6. (Pubitemid 35300768)
16. (B) receptors in the modulation of anxiety- and antidepressant-like behaviour. Neuropsychopharmacology 2004;29(6):1050-62.
17. Clarke PB, Kumar R. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 1983;78(2):329-37. (Pubitemid 13192204)
18. Picciotto MR, Zoli M, Léna C, Bessis A, Lallemand Y, Le Novère N, et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 1995;374(6517):65-7.
19. Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, Léna C, Le Novère N, de Kerchove d'Exaerde A, et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 1999;398(6730):805-10.
20. Biala G, Kruk M, Budzynska B. Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test. J Physiol Pharmacol 2009;60(2):113-22.
21. B receptor site distribution in the rat central nervous system. Neuroscience 1987;20(2):365-83.
22. Young AB, Chu D. Distribution of GABAA and GABAB receptors in mammalian brain: potential targets for drug development. Drug Dev Res 1990;21:161-7.
23. (B) receptors in the dystonic hamster: pronounced antidystonic effects of baclofen after striatal injections. Neuroscience 2009;162(2):423-30.
24. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF, et al. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 1992;12(7):2765-84.
25. Marks MJ, Smith KW, Collins AC. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. J Pharmacol Exp Ther 1998;285(1):377-86. (Pubitemid 28207609)
26. 2 nicotinic receptor agonist [3H]-epibatidine. Pol J Pharmacol 2003;55(1):17-23.
27. Terry Jr AV, Gearhart DA, Mahadik SP, Warsi S, Waller JL. Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain. Neuroscience 2006;140(4):1277-87. (Pubitemid 43928280)
28. Aso E, Maldonado R, Balerio G. Baclofen modifies nicotine behavioural responses, but not motivational manifestations of nicotine withdrawal in mice. Biocell 2007;31(1):98 [Abstract 66].
29. Varani AP, Moutinho LM, Calvo M, Balerio GN. Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal. Drug Alcohol Depend 2011;119(1-2):e5-12.
30. SENASA. (Resolución 617/2002): Requisitos, condiciones y procedimientos para la habilitación técnica de laboratorios que posean bioterios de producción, mantenimiento y local de experimentación.
31. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985;14(3):149-67. (Pubitemid 16239568)
32. Corrigall WA, Coen KM, Adamson KL, Chow JZ. Response of nicotine self-administration in the rat to manipulations of mu-opioid and γ-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology 2000;149:107-14. (Pubitemid 30238947)
33. Le Foll B, Wertheim CE, Goldberg SR. Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats. Neurosci Lett 2008;443(3):236-40.
34. Fattore L, Spano MS, Cossu G, Scherma M, Fratta W, Fadda P. Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents. Eur Neuropsychopharmacol 2009;19(7):487-98.
35. B receptor ligands in animal tests of depression and anxiety. Pharmacol Rep 2007;59(6):645-55.
36. B receptor stimulation accentuates the locomotor effects of morphine in mice bred for extreme sensitivity to the stimulant effects of ethanol. Pharmacol Biochem Behav 2006;85(4):697-704.
37. Kalivas PW, Jackson D, Romanidies A, Wyndham L, Duffy P. Involvement of pallidothalamic circuitry in working memory. Neuroscience 2001;104(1):129-36. (Pubitemid 32322619)
38. Abraini JH, Kriem B, Balon N, Rostain JC, Risso JJ. Gamma-aminobutyric acid neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth Analg 2003;96(3):746-9. (Pubitemid 36245563)
39. Picciotto MR, Brunzell DH, Caldarone BJ. Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 2002;13(9):1097-106. (Pubitemid 34722033)
40. File SE, Cheeta S, Kenny PJ, Ouagazzal A-M. Roles of the dorsal raphe nucleus, lateral septum and dorsal hippocampus in nicotineǐs effects on axiety. Soc Neurosci 1999;24 [Abstract: 1981].
41. Ouagazzal AM, Kenny PJ, File SE. Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety. Eur J Neurosci 1999;11(11):3957-62. (Pubitemid 29537575)
42. Damaj MI, Glennon RA, Martin BR. Involvement of the serotonergic system in the hypoactive and antinociceptive effects of nicotine in mice. Brain Res Bull 1994;33(2):199-203. (Pubitemid 124009936)
43. Riekkinen Jr P, Sirviö J, Riekkinen M. Serotonin depletion decreases the therapeutic effect of nicotine, but not THA in medial septal-lesioned rats. Brain Res 1994;662(1-2):95-102. (Pubitemid 24326867)
44. 3 receptor antagonist ondansetron. Life Sci 1997;61(16):249-54.
45. Engberg G, Erhardt S, Sharp T, Hajós M. Nicotine inhibits firing activity of dorsal raphe 5-HT neurones in vivo. Naunyn Schmiedebergs Arch Pharmacol 2000;362(1):41-5. (Pubitemid 30431634)